EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 2 February 2014. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2013 (Oct'13 to Dec'13), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 1,589.34 million with consolidated EPS of Tk. 3.30 as against Tk. 1,194.34 million and Tk. 2.48 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 4,104.82 million with consolidated EPS of Tk. 8.52 for the period of nine months (Apr'13 to Dec'13) ended on 31.12.2013 as against Tk. 3,245.10 million and Tk. 6.73 respectively for the same period of the previous year.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf6b5a6b000040066b1b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.